RAFAEL HOLDINGS, INC. Amortization of Debt Discount (Premium)
RAFAEL HOLDINGS, INC. (RFL) reported Amortization of Debt Discount (Premium) of -$285.00 thousand for the 12-month period ending 2025-07-31, per its 10-K filed 2025-10-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2026-06-11
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-07-31 was $0.00.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-04-30 was $0.00.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2025-01-31 was -$28.00K.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for the quarter ending 2024-10-31 was -$257.00K.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2025 was -$285.00K.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2024 was -$1.89M.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2020 was $54.00K, a 217.65% increase from fiscal 2019.
- RAFAEL HOLDINGS, INC. amortization of debt discount (premium) for fiscal 2019 was $17.00K, a 97.41% decline from fiscal 2018.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2025-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2026-06-11 | -$28.00K derived: sum of 3 quarters · filed 2026-06-11 | -$285.00K 10-K · filed 2025-10-29 |
| 2025-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-06-11 | -$28.00K derived: sum of 2 quarters · filed 2026-06-11 | -$285.00K 10-Q · filed 2026-06-11 | -$678.00K derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-03-16 | -$285.00K 10-Q · filed 2026-03-16 | -$678.00K derived: sum of 3 quarters · filed 2026-03-16 | -$1.12M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | -$257.00K 10-Q · filed 2025-12-12 | -$650.00K derived: sum of 2 quarters · filed 2025-12-12 | -$1.10M derived: sum of 3 quarters · filed 2025-12-12 | -$1.63M derived: sum of 4 quarters · filed 2025-12-12 |
| 2024-07-31 | -$393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-29 | -$839.00K derived: sum of 2 quarters · filed 2025-10-29 | -$1.37M derived: sum of 3 quarters · filed 2025-10-29 | -$1.89M 10-K · filed 2025-10-29 |
| 2024-04-30 | -$446.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-06-11 | -$979.00K derived: sum of 2 quarters · filed 2025-06-11 | -$1.50M 10-Q · filed 2025-06-11 | |
| 2024-01-31 | -$533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-03-14 | -$1.05M 10-Q · filed 2025-03-14 | ||
| 2023-10-31 | -$519.00K 10-Q · filed 2024-12-11 | |||
| 2022-04-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | $250.00K derived: sum of 2 quarters · filed 2022-06-14 | $375.00K 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $125.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-03-17 | $250.00K 10-Q · filed 2022-03-17 | ||
| 2021-10-31 | $125.00K 10-Q/A · filed 2022-02-28 | |||
| 2020-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $0.00 derived: sum of 2 quarters · filed 2021-10-18 | $0.00 derived: sum of 3 quarters · filed 2021-10-18 | $54.00K 10-K · filed 2021-10-18 |
| 2020-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-06-14 | $0.00 derived: sum of 2 quarters · filed 2021-06-14 | $54.00K 10-Q · filed 2021-06-14 | $60.00K derived: sum of 4 quarters · filed 2021-06-14 |
| 2020-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-03-17 | $54.00K 10-Q · filed 2021-03-17 | $60.00K derived: sum of 3 quarters · filed 2021-03-17 | $66.00K derived: sum of 4 quarters · filed 2021-03-17 |
| 2019-10-31 | $54.00K 10-Q · filed 2020-12-15 | $60.00K derived: sum of 2 quarters · filed 2020-12-15 | $66.00K derived: sum of 3 quarters · filed 2020-12-15 | |
| 2019-07-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-29 | $12.00K derived: sum of 2 quarters · filed 2020-10-29 | $17.00K 10-K · filed 2020-10-29 | |
| 2019-04-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-09 | $11.00K 10-Q · filed 2020-06-09 | ||
| 2019-01-31 | $5.00K 10-Q · filed 2020-03-05 | |||
| 2018-07-31 | $657.00K 10-K · filed 2019-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |